stockrowLivaNova PLC
LIVN Healthcare Medical Devices
LivaNova PLC’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 10.7% from fiscal 2024.
- Revenue
- +9.89%
- EPS
- +27.0%
- Free cash flow
- −31.0%
- Total debt
- −31.2%
Quarter to September 2026, against a year earlier
Follow LIVN
Alert me
LivaNova PLC (LIVN) Book value per share
LivaNova PLC's book value per share at the end of fiscal 2025 was 22.0×, down 9.62% from 24.3× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 24.9×. Over the past ten years it has ranged from 0.0× (fiscal 2015) to 37.7× (fiscal 2017); the current reading is higher than 25% of that period. LivaNova PLC ranks 18th of 149 Medical Devices companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 22.0× | (9.62%) |
| FY2024 | 24.3× | 2.76% |
| FY2023 | 23.7× | 4.88% |
| FY2022 | 22.6× | (11.67%) |
| FY2021 | 25.6× | 12.01% |
| FY2020 | 22.8× | (20.24%) |
| FY2019 | 28.6× | (7.70%) |
| FY2018 | 31.0× | (17.74%) |
| FY2017 | 37.7× | 7.90% |
| FY2016 | 34.9× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 24.9× | 3.31% |
| Jun 2026 | 24.1× | 8.85% |
| Mar 2026 | 22.1× | 0.69% |
| Dec 2025 | 22.0× | 3.85% |
| 47 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| BIO Bio-Rad Laboratories, Inc. compare | 284× |
| ITGR Integer Holdings Corporation compare | 50.7× |
| LIVN LivaNova PLC | 24.9× |
| HAE Haemonetics Corporation compare | 19.7× |
| BRKR Bruker Corporation compare | 15.1× |
| NEOG Neogen Corporation compare | 9.6× |
| AXGN AxoGen, Inc. compare | 9.0× |
| TXG 10x Genomics compare | 6.4× |
| IRTC iRhythm Holdings, Inc. compare | 5.4× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on LIVN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement